| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/30/2018 | AIRXPANDERS INC | AXP | Purchase | Common Stock | 19.7M | $0.17 | $3.3M | By Vivo Ventures Fund VII, L.P. | 08/30/2018 |
| 08/30/2018 | AIRXPANDERS INC | AXP | Purchase | Common Stock | 429.6k | $0.17 | $71.8k | By Vivo Ventures VII Affiliates Fund, L.P. | 08/30/2018 |
| 11/18/2016 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 440.4k | $22.72 | $10M | By Vivo Ventures Fund VII, L.P. | 11/16/2016 |
| 11/18/2016 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 9.6k | $22.72 | $218.1k | By Vivo Ventures VII Affiliates Fund, L.P. | 11/16/2016 |
| 11/16/2016 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 448.1k | $23.25 | $10.4M | By Vivo Ventures Fund VII, L.P. | 11/16/2016 |
| 11/16/2016 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 9.8k | $27.30 | $266.6k | By Vivo Ventures VII Affiliates Fund, L.P. | 11/16/2016 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series C Preferred Stock | 1.3M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series B Preferred Stock | 38.8k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series B Preferred Stock | 1.8M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series C Preferred Stock | 29.3k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series A Preferred Stock | 184.6k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Series A Preferred Stock | 8.5M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Purchase | Common Stock | 9.7k | $11.00 | $106.6k | By Vivo Ventures VII Affiliates Fund, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Common Stock | 73.2k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Purchase | Common Stock | 444.8k | $11.00 | $4.9M | By Vivo Ventures Fund VII, L.P. | 10/13/2015 |
| 10/13/2015 | Aclaris Therapeutics, Inc. | ACRS | Conversion | Common Stock | 3.4M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 10/13/2015 |
| 10/07/2015 | Aclaris Therapeutics, Inc. | ACRS | Purchase | Common Stock | 285 | $11.00 | $3.1k | By Vivo Ventures VII Affiliates Fund, L.P. | 10/07/2015 |
| 10/07/2015 | Aclaris Therapeutics, Inc. | ACRS | Purchase | Common Stock | 13.1k | $11.00 | $143.7k | By Vivo Ventures Fund VII, L.P. | 10/07/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Conversion | Series D Preferred Stock | 45k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Conversion | Series D Preferred Stock | 2.1M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Purchase | Common Stock | 4.7k | $17.00 | $79.8k | By Vivo Ventures VII Affiliates Fund, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Purchase | Common Stock | 215.3k | $17.00 | $3.7M | By Vivo Ventures Fund VII, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Other (acquisition) | Common Stock | 2.3k | $5.22 | $12.1k | By Vivo Ventures VII Affiliates Fund, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Other (acquisition) | Common Stock | 106.6k | $5.22 | $556.2k | By Vivo Ventures Fund VII, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Conversion | Common Stock | 45k | $0.00 | $0 | By Vivo Ventures VII Affiliates Fund, L.P. | 07/21/2015 |
| 07/21/2015 | Sierra Oncology, Inc. | SRRA | Conversion | Common Stock | 2.1M | $0.00 | $0 | By Vivo Ventures Fund VII, L.P. | 07/21/2015 |